No Data
No Data
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
Beam Therapeutics (BEAM) Upgraded to Buy: What Does It Mean for the Stock?
Express News | Beam Therapeutics Inc : RBC Cuts Target Price to $27 From $35
Here's Why We're Not At All Concerned With Beam Therapeutics' (NASDAQ:BEAM) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose mo
Beam Therapeutics(BEAM.US) Officer Sells US$1.47 Million in Common Stock
$Beam Therapeutics(BEAM.US)$ Officer Evans John M. sold 60,000 shares of common stock on Jun 27, 2024 at an average price of $24.5026 for a total value of $1.47 million.Source: Announcement What is st
Beam Therapeutics Insider Sold Shares Worth $1,470,156, According to a Recent SEC Filing
John M. Evans, Director, CEO, on June 27, 2024, sold 60,000 shares in Beam Therapeutics (BEAM) for $1,470,156. Following the Form 4 filing with the SEC, Evans has control over a total of 1,101,343 sha
No Data